Heterozygous pathogenic variants in the SGMS2 gene, encoding the sphingomyelin-synthesizing enzyme sphingomyelin synthase 2, cause a rare monogenic form of osteoporosis with low bone density, fractures, bone deformities, sclerotic cranial lesions, and occasionally, neurological symptoms. This evidence concerns the gene SGMS2 and osteoporosis.